{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:52:47Z","timestamp":1775238767755,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.pnpbp.2019.109707","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T11:28:04Z","timestamp":1563535684000},"page":"109707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Preclinical characterization of ACH-000029, a novel anxiolytic compound acting on serotonergic and alpha-adrenergic receptors"],"prefix":"10.1016","volume":"95","author":[{"given":"Hatylas","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Watanabe","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valter","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Mascarello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano Ruch Werneck","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2019.109707_bb0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1254\/jjp.76.297","article-title":"Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice","volume":"76","author":"Abe","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cbdv.200690001","article-title":"Synthesis and biological evaluation of new quinazoline and cinnoline derivatives as potential atypical antipsychotics","volume":"3","author":"Alvarado","year":"2006","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.euroneuro.2004.12.002","article-title":"Anxiogenic effects of Sumatriptan in panic disorder: a double-blind, placebo-controlled study","volume":"15","author":"Amital","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109707_bb0020","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1210\/en.2009-1234","article-title":"Lighting up neuronal pathways: the development of a novel transgenic rat that identifies Fos-activated neurons using a red fluorescent protein","volume":"150","author":"Appleyard","year":"2009","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109707_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.31887\/DCNS.2017.19.2\/bbandelow","article-title":"Treatment of anxiety disorders","volume":"19","author":"Bandelow","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109707_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jep.2011.11.047","article-title":"Anxiolytic-like effects of acute and chronic treatment with Achillea millefolium L. extract","volume":"140","author":"Baretta","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0035","first-page":"15","article-title":"The noradrenergic symptom cluster: clinical expression and neuropharmacology","volume":"7","author":"Blier","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109707_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123604","article-title":"Time course of immediate early gene protein expression in the spinal cord following conditioning stimulation of the sciatic nerve in rats","volume":"10","author":"Bojovic","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(99)00072-6","article-title":"Behavioral effects of flibanserin","volume":"64","author":"Borsini","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109707_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.31887\/DCNS.2015.17.3\/mbourin","article-title":"Animal models for screening anxiolytic-like drugs: a perspective","volume":"17","author":"Bourin","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/2327-6924.12432","article-title":"The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U.S. military veterans","volume":"29","author":"Breen","year":"2017","journal-title":"J. Am. Assoc. Nurse Pract."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(86)90051-8","article-title":"Major tranquillizers can be distinguished from minor tranquillizers on the basis ofeffects on marble burying and swim-induced grooming in mice","volume":"126","author":"Broekkamp","year":"1986","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.109707_bb0080","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nn.4101","article-title":"Resolving the neural circuits of anxiety","volume":"18","author":"Calhoon","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109707_bb0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000447034","article-title":"The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature","volume":"85","author":"Carvalho","year":"2016","journal-title":"Psychother. Psychosom."},{"issue":"21","key":"10.1016\/j.pnpbp.2019.109707_bb0090","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1073\/pnas.94.21.11589","article-title":"Decreased blood pressure response in mice deficient of the \u03b11b-adrenergic receptor","volume":"94","author":"Cavalli","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0095","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0028-3908(02)00292-7","article-title":"Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress","volume":"43","author":"Cecchi","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"issue":"Suppl. 4","key":"10.1016\/j.pnpbp.2019.109707_bb0105","first-page":"S22","article-title":"A comparison of varying \u03b1-blockers and other pharmacotherapy options for lower urinary tract symptoms","volume":"7","author":"Chapple","year":"2005","journal-title":"Rev. Urol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuropharm.2014.11.016","article-title":"Activation of 5-HT2a receptors in the basolateral amygdala promotes defeat-induced anxiety and the acquisition of conditioned defeat in Syrian hamsters","volume":"90","author":"Clinard","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0120","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0091-3057(81)90007-1","article-title":"Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines","volume":"15","author":"Crawley","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0125","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1476-5381.2011.01362.x","article-title":"The age of anxiety: role of animal models of anxiolytic action in drug discovery","volume":"164","author":"Cryan","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/npp.2015.178","article-title":"Stress modulation of opposing circuits in the bed nucleus of the stria terminalis","volume":"41","author":"Daniel","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0135","article-title":"Distinct effect of 5-HT1A and 5-HT2A receptors in the medial nucleus of the amygdala on tonic immobility behavior","volume":"15","author":"de Paula","year":"2016","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109707_bb0140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/jm301297f","article-title":"Demystifying brain penetration in central nervous system drug discovery","volume":"56","author":"Di","year":"2013","journal-title":"Miniperspective. J. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.109707_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(95)01486-1","article-title":"Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety","volume":"713","author":"Duncan","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(86)90325-6","article-title":"Buspirone: review of its pharmacology and current perspectives on its mechanism of action","volume":"80","author":"Eison","year":"1986","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109707_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/neu.2015.53","article-title":"Effects of repeated asenapine in a battery of tests for anxiety-like behaviours in mice","volume":"28","author":"Ene","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0160","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.janxdis.2012.07.009","article-title":"Pharmacological treatment of anxiety disorders: current treatments and future directions","volume":"26","author":"Farach","year":"2012","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0165","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ardp.201400174","article-title":"Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands","volume":"347","author":"Fiorino","year":"2014","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0175","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF02244254","article-title":"Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal","volume":"103","author":"Goudie","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0185","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"3","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109707_bb0190","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2165\/11591710-000000000-00000","article-title":"Antipsychotic pharmacotherapy and orthostatic hypotension","volume":"25","author":"Grugger","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.vascn.2014.07.003","article-title":"Role of 5-HT1A- and 5-HT2A receptors for the murine model of the serotonin syndrome","volume":"70","author":"Haberzettl","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0200","first-page":"252","article-title":"Structured evaluation of rodent behavioral tests used in drug discovery research","volume":"8","author":"H\u00e5nell","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109707_bb0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0091-3057(98)00031-8","article-title":"A new approach to the light\/dark test procedure in mice","volume":"60","author":"Hasco\u00ebt","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/DHPS.S7634","article-title":"Antidepressant-associated sexual dysfunction: impact, effects, and treatment","volume":"2","author":"Higgins","year":"2010","journal-title":"Drug Healthc. Patient Saf."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0215","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2016.11.035","article-title":"Outbred CD1 mice are as suitable as inbred C57BL\/6J mice in performing social tasks","volume":"637","author":"Hsieh","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109707_bb0230","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1254\/jjp.68.65","article-title":"5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice","volume":"68","author":"Ichimaru","year":"1995","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00401402","article-title":"Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse","volume":"13","author":"Irwin","year":"1968","journal-title":"Psychopharmacologia"},{"issue":"7","key":"10.1016\/j.pnpbp.2019.109707_bb0240","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/FBP.0b013e32834afebe","article-title":"Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and\/or anxiety","volume":"22","author":"Jimenez-Gomez","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881110367448","article-title":"The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies","volume":"25","author":"Kalk","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109707_bb0250","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.celrep.2014.12.014","article-title":"Mapping social behavior-induced brain activation at cellular resolution in the mouse","volume":"10","author":"Kim","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0255","first-page":"3","article-title":"Whole-brain mapping of neuronal activity in the learned helplessness model of depression","volume":"10","author":"Kim","year":"2016","journal-title":"Front. Neural Circ."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109707_bb0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2045125313500982","article-title":"High-dose prazosin for the treatment of post-traumatic stress disorder","volume":"4","author":"Koola","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0270","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jhet.526","article-title":"Evaluation of 1-arylpiperazine derivative of hydroxybenzamides as 5-HT1A and 5-HT7 serotonin receptor ligands: an experimental and molecular modeling approach","volume":"48","author":"Kowalski","year":"2011","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0280","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/mp.2016.1","article-title":"Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders","volume":"21","author":"Lebow","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0285","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0960-894X(00)00169-4","article-title":"Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists","volume":"10","author":"Li","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109707_bb0290","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/jpet.114.213793","article-title":"Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator","volume":"350","author":"Maeda","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"136","key":"10.1016\/j.pnpbp.2019.109707_bb0295","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2017.05.003","article-title":"Quinazoline based \u03b11-adrenoreceptor antagonists with potent antiproliferative activity in human prostate cancer cell lines","volume":"18","author":"Maestri","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0300","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","article-title":"Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders","volume":"28","author":"Marek","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109707_bb0305","first-page":"205","article-title":"Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features","volume":"2","author":"Marken","year":"2000","journal-title":"Prim Care Companion J. Clin. Psychiatry."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0160-5402(85)90019-1","article-title":"Dissociation of head twitches and tremors during the study of interactions with 5-hydroxytryptophan in mice","volume":"13","author":"Martin","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2015.01.009","article-title":"Structure and function of serotonin G protein-coupled receptors","volume":"150","author":"McCorvy","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0320","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2018.04.002","article-title":"The cerebellum in fear and anxiety-related disorders","volume":"85","author":"Moreno-Rius","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109707_bb0325","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.pnpbp.2005.08.007","article-title":"Role of brain norepinephrine in the behavioral response to stress","volume":"29","author":"Morilak","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109707_bb0330","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.pbb.2011.09.005","article-title":"A role for 5-HT1A receptors in the basolateral amygdala in the development of conditioned defeat in Syrian hamsters","volume":"100","author":"Morrison","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0335","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/14728214.2015.1049996","article-title":"Emerging drugs for the treatment of anxiety","volume":"20","author":"Murrough","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2019.109707_bb0340","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","article-title":"Evaluation of marble-burying behavior as a model of anxiety","volume":"38","author":"Njung\u2019e","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.109707_bb0350","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2010.03.015","article-title":"The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors","volume":"59","author":"Nojimoto","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0355","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/14737175.2016.1173545","article-title":"New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine","volume":"16","author":"Orsolini","year":"2016","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0360","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00505653","article-title":"Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome","volume":"316","author":"Ortmann","year":"1981","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109707_bb0365","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nmeth.2477","article-title":"Mapping brain circuitry with a light microscope","volume":"10","author":"Osten","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1025389031000111311","article-title":"Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models","volume":"6","author":"Overstreet","year":"2003","journal-title":"Stress"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0375","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0380","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pbb.2013.09.001","article-title":"Anxiolytic-like effects of carvacryl acetate, a derivative of carvacrol, in mice","volume":"112","author":"Pires","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0385","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cellsig.2010.03.019","article-title":"5-HT1A receptor-regulated signal transduction pathways in brain","volume":"22","author":"Polter","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0390","first-page":"191","article-title":"5-HT1A receptor as a key player in the brain 5-HT system","volume":"24","author":"Popova","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0395","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/1521-4184(200011)333:11<381::AID-ARDP381>3.0.CO;2-A","article-title":"Synthesis and analgesic activity of some quinazoline analogs of anpirtoline","volume":"333","author":"R\u00e1dl","year":"2000","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0400","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/alcalc\/agw082","article-title":"Prazosin prevents increased anxiety behavior that occurs in response to stress during alcohol deprivations","volume":"52","author":"Rasmussen","year":"2017","journal-title":"Alcohol. Alcohol."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.109707_bb0405","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.cell.2016.05.007","article-title":"Mapping of brain activity by automated volume analysis of immediate early genes","volume":"165","author":"Renier","year":"2016","journal-title":"Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2019.109707_bb0410","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0415","doi-asserted-by":"crossref","first-page":"155S","DOI":"10.1016\/0895-7061(96)00291-9","article-title":"Orthostatic hypotension: how to avoid it during antihypertensive therapy","volume":"11","author":"Rieckert","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fpsyt.2017.00089","article-title":"Behavioral effects of a novel benzofuranyl-piperazine serotonin-2C receptor agonist suggest a potential therapeutic application in the treatment of obsessive-compulsive disorder","volume":"8","author":"Rodriguez","year":"2017","journal-title":"Front Psychiatr."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0425","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(82)90406-X","article-title":"Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity","volume":"86","author":"Sanghera","year":"1982","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109707_bb0435","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0440","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2018.11.015","article-title":"Brain sub\/region-specific effects of olanzapine on c-Fos expression of chronically socially isolated rats","volume":"396","author":"Stanisavljevi\u0107","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0445","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1214\/aos\/1074290335","article-title":"The positive false discovery rate: a Bayesian interpretation and the q-value","volume":"31","author":"Storey","year":"2003","journal-title":"Ann. Stat."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0450","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/jpet.102.033282","article-title":"Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons","volume":"302","author":"Szabo","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0455","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pnpbp.2012.05.017","article-title":"The effects of the co-administration of the \u03b1\u2081-adrenoreceptor antagonist prazosin on the anxiolytic effect of citalopram in conditioned fear stress in the rat","volume":"39","author":"Takamura","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109707_bb0460","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI200214001","article-title":"The \u03b11D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction","volume":"109","author":"Tanoue","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0465","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2015.01.014","article-title":"Limbic circuitry of the midline thalamus","volume":"54","author":"Vertes","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0475","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.1123432","article-title":"Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice","volume":"313","author":"Weisstaub","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2019.109707_bb0480","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000481791","article-title":"Stimulation of anxiety-like behavior via ERK pathway by competitive serotonin receptors 2A and 1A in post-traumatic stress disordered mice","volume":"25","author":"Xiang","year":"2017","journal-title":"Neurosignals"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109707_bb0485","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0091-3057(91)90077-F","article-title":"Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light\/dark test","volume":"40","author":"Young","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0490","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1021\/cc049970z","article-title":"A new class of arylpiperazine derivatives: the library synthesis on SynPhase lanterns and biological evaluation on serotonin 5-HT1A and 5-HT2A receptors","volume":"6","author":"Zajdel","year":"2004","journal-title":"J. Comb. Chem."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.109707_bb0495","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0169-328X(02)00556-9","article-title":"Differential induction and decay curves of c-fos and zif268 revealed through dual activity maps","volume":"109","author":"Zangenehpour","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pnpbp.2019.109707_bb0500","doi-asserted-by":"crossref","first-page":"42676","DOI":"10.1038\/srep42676","article-title":"Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619301022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619301022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:48:31Z","timestamp":1759520911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584619301022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":91,"alternative-id":["S0278584619301022"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109707","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical characterization of ACH-000029, a novel anxiolytic compound acting on serotonergic and alpha-adrenergic receptors","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109707"}}